Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2008-008597-31Phase 2Active
Phase 2 trial of ketamine and esketamine in Shock (2 arms), sponsored by Skåne University Hospital. Primary endpoints: Cerebral blood flow and blood volume comparison and ASL-MRI application evaluation. Started Apr 2009; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2008-008597-31.